ChemoCentryx Major Shareholder Bvf Partners P/Il Buys 1,289,354 Shares (CCXI)
ChemoCentryx (NASDAQ:CCXI) major shareholder Bvf Partners P/Il acquired 1,289,354 shares of ChemoCentryx stock in a transaction that occurred on Wednesday, October 9th. The shares were purchased at an average cost of $5.34 per share, with a total value of $6,885,150.36. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.
ChemoCentryx (NASDAQ:CCXI) traded down 2.46% on Thursday, hitting $5.15. 501,262 shares of the company’s stock traded hands. ChemoCentryx has a 52-week low of $5.10 and a 52-week high of $14.96. The stock has a 50-day moving average of $6.85 and a 200-day moving average of $11.61. The company’s market cap is $220.6 million.
ChemoCentryx (NASDAQ:CCXI) last announced its earnings results on Monday, August 12th. The company reported ($0.23) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.28) by $0.05. The company had revenue of $1.90 million for the quarter, compared to the consensus estimate of $1.48 million. During the same quarter last year, the company posted ($0.30) earnings per share. Analysts expect that ChemoCentryx will post $-1.03 EPS for the current fiscal year.
Separately, analysts at JPMorgan Chase & Co. downgraded shares of ChemoCentryx from an “overweight” rating to a “neutral” rating in a research note to investors on Tuesday, September 10th. They now have a $7.00 price target on the stock, down previously from $11.00.
ChemoCentryx is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.